These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1797947)

  • 1. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Calandra S; Salvati P; Ferti C; Patrono C
    J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Marchi L; Calandra S; Salvati P
    Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
    Calandra S; Tarugi P; Ghisellini M; Gherardi E
    Exp Mol Pathol; 1983 Dec; 39(3):282-99. PubMed ID: 6416889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome.
    Calandra S; Gherardi E; Fainaru M; Guaitani A; Bartosek I
    Biochim Biophys Acta; 1981 Aug; 665(2):331-8. PubMed ID: 6793079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.
    Kushwaha RS; McMahan CA; Mott GE; Carey KD; Reardon CA; Getz GS; McGill HC
    J Lipid Res; 1991 Dec; 32(12):1929-40. PubMed ID: 1687745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E; Calandra S
    Biochim Biophys Acta; 1982 Feb; 710(2):188-96. PubMed ID: 7066357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein metabolism in experimental nephrosis.
    Marsh JB
    Proc Soc Exp Biol Med; 1996 Nov; 213(2):178-86. PubMed ID: 8931662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid and apolipoprotein levels in patients with nephrotic syndrome.
    Ohta T; Matsuda I
    Clin Chim Acta; 1981 Dec; 117(2):133-43. PubMed ID: 6796292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in nephrotic rats induced by daunomycin injection.
    Morisaki N; Matsuoka N; Saito Y; Kumagai A
    Metabolism; 1984 May; 33(5):405-10. PubMed ID: 6717274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
    Krause BR; Newton RS
    J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis.
    Marshall JF; Apostolopoulos JJ; Brack CM; Howlett GJ
    Biochim Biophys Acta; 1990 Feb; 1042(3):271-9. PubMed ID: 2306478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
    Sestak TL; Alavi N; Subbaiah PV
    Kidney Int; 1989 Aug; 36(2):240-8. PubMed ID: 2779094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene.
    Marsh JB; Diffenderfer MR; Fisher EA; Sowden M; Dong M; Paterniti JR; Burkey BF
    J Lipid Res; 1996 May; 37(5):1113-24. PubMed ID: 8725162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.
    Vaziri ND; Liang K; Parks JS
    Am J Physiol Renal Physiol; 2001 May; 280(5):F823-8. PubMed ID: 11292624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein metabolism in the nephrotic syndrome.
    Marsh JB
    Front Biosci; 2002 Aug; 7():e326-38. PubMed ID: 12133820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apolipoprotein A-1 and E gene expression in liver and intestine of nephrotic and pair-fed rats.
    Panduro A; Castrillón L; Pedraza-Chaverrí J; Vargas F; Ibarra-Rubio ME
    Nephron; 1993; 65(1):100-7. PubMed ID: 8413767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.